デフォルト表紙
市場調査レポート
商品コード
1629826

モジュール式ベンチトップ発酵槽システムの世界市場-2024~2031年

Global Modular Bench-top Fermenter System Market - 2024-2031


出版日
ページ情報
英文 176 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
モジュール式ベンチトップ発酵槽システムの世界市場-2024~2031年
出版日: 2024年12月30日
発行: DataM Intelligence
ページ情報: 英文 176 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のモジュール式ベンチトップ発酵槽システム市場は、2023年に1億9,000万米ドルに達し、2031年には3億2,500万米ドルに達すると予測され、予測期間2024~2031年のCAGRは6.9%で成長すると予測されています。

モジュール式ベンチトップ発酵槽システムは、コンパクトで実験室に適したセットアップで、制御された条件下で微生物、細胞、組織を培養する高度なバイオプロセシングツールです。この多用途でカスタマイズ可能なシステムは、バイオテクノロジー、医薬品、食品製造、バイオ燃料に理想的です。温度、pH、酸素レベル、撹拌などの主要パラメーターを正確に制御し、最適な発酵条件を確保します。モジュラー設計により、拡張性と柔軟性が容易に得られるため、調査や製造業者は必要に応じてシステムを拡張・変更することができます。

モジュール式ベンチトップ発酵槽には、Ambr 250 Modular、BioXplorer 100、FerMac 200、Genesis Seriesがあります。Ambr 250 Modularは迅速なプロセス開発と最適化のために設計され、BioXplorer 100は好気性発酵用に最適化され、リアルタイムデータ取得で少量プロセスを可能にします。FerMac 200はスタック可能なモジュールで発酵パラメーターを柔軟に制御でき、Genesis Seriesはベンチトップから大型SIPシステムへと移行し、より広範な用途に対応します。

市場力学:

促進要因と阻害要因

バイオテクノロジー研究開発の需要拡大

世界のモジュール式ベンチトップ発酵槽システム市場は、医薬品、バイオ燃料、食品生産などの産業におけるバイオテクノロジー研究開発の需要の高まりにより成長しています。これらのシステムは、コンパクトで適応性の高い方法で微生物発酵プロセスを正確に制御し、研究者やメーカーが条件を最適化し、小規模な実験室での実験から大規模な工業生産プロセスへとスケールアップすることを可能にします。持続可能なエネルギー源とグリーンテクノロジーへの注目が高まる中、モジュール式発酵槽はバイオ燃料生産に不可欠です。操作のスケールアップにおける柔軟性と、異なる微生物株に対するカスタマイズ性により、バイオテクノロジー分野の進化する要求に適しています。その結果、モジュール式ベンチトップ発酵槽の採用が世界の成長の原動力となっています。

高い初期コストとメンテナンス費用

世界のモジュール式ベンチトップ発酵槽システム市場は、高い初期取得コストと継続的なメンテナンス費用による課題に直面しています。これらのコストは、特に小規模の研究室や新興バイオテクノロジー企業にとって、特に予算に制約のある地域では、これらのシステムの採用を遅らせる可能性があります。また、セットアップ、キャリブレーション、継続的なメンテナンスには専門的な技術知識が必要となるため、メンテナンスや運用にも多大な費用がかかります。

例えば、Ambr 250 Modular、Winpact One Fermentation System(FS-06)、BioXplorer 100のようなモジュール式ベンチトップ発酵槽システムは、その機能、容量、製造業者によってコストが異なります。Ambr 250 Modularはプロセス最適化のために設計され、2~8個のシングルユース・バイオリアクターを統合して稼動させることができ、価格は30,000から100,000ドルです。Winpact One Fermentation System(FS-06)は、多用途でコンパクトなシステムで、価格は10,000ドルから15,000ドルです。BioXplorer 100はパラレルバイオリアクタープラットフォームで、価格は20,000ドルから50,000ドルです。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • バイオテクノロジー研究開発の需要の高まり
    • 抑制要因
      • 初期費用と維持費が高い
    • 機会
      • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析

第6章 タイプ別

  • 温度・撹拌制御モジュール
  • 酸素コントローラー

第7章 容量別

  • 小(最大5L)
  • 中(5L~50L)
  • 大型(50L以上)

第8章 用途別

  • 微生物発酵
  • 細胞培養
  • 生化学生産
  • ワクチン製造
  • 飲食品加工

第9章 エンドユーザー別

  • 製薬・バイオテクノロジー業界
  • 学術研究機関
  • 食品・飲料業界
  • 化学産業
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況・シェア分析
  • M&A分析

第12章 企業プロファイル

  • Electrolab Biotech
    • 会社概要
    • 製品ポートフォリオと概要
    • 財務概要
    • 主な発展
  • Eppendorf AG
  • Thermo Fisher Scientific Inc
  • GE Healthcare Life Sciences
  • Sartorius AG
  • Merck KGaA
  • Bioengineering AG
  • Applikon Biotechnology
  • Finesse Solutions(A Danaher Company)
  • Labfors(Infors HT)

第13章 付録

目次
Product Code: MD8879

The global modular bench-top fermenter system market reached US$ 190 million in 2023 and is expected to reach US$ 325 million by 2031, growing at a CAGR of 6.9% during the forecast period 2024-2031.

Modular bench-top fermenter systems are advanced bioprocessing tools that cultivate microorganisms, cells, or tissues under controlled conditions in a compact, laboratory-friendly setup. These versatile and customizable systems are ideal for biotechnology, pharmaceuticals, food production, and biofuels. They offer precise control over key parameters like temperature, pH, oxygen levels, and agitation, ensuring optimal fermentation conditions. Their modular design allows for easy scalability and flexibility, allowing researchers and manufacturers to expand or modify the system as needed.

Modular benchtop fermentors include the Ambr 250 Modular, BioXplorer 100, FerMac 200, and Genesis Series. The Ambr 250 Modular is designed for rapid process development and optimization, while the BioXplorer 100 is optimized for aerobic fermentation and allows low-volume processes with real-time data acquisition. The FerMac 200 offers stackable modules for flexibility in controlling fermentation parameters, and the Genesis Series transitions from benchtop to larger SIP systems for more extensive applications.

Market Dynamics: Drivers & Restraints

Growing Demand for Biotechnology Research and Development

The global modular bench-top fermenter system market is growing due to the growing demand for biotechnology research and development in industries like pharmaceuticals, biofuels, and food production. These systems offer precise control over microbial fermentation processes in a compact, adaptable manner, enabling researchers and manufacturers to optimize conditions and scale up from small laboratory experiments to larger industrial production processes. With the growing focus on sustainable energy sources and green technology, modular fermenters are essential in biofuel production. Their flexibility in scaling operations and customization for different microbial strains make them well-suited to the evolving demands of the biotechnology sector. As a result, the adoption of modular bench-top fermenters is driving global growth.

High Initial Cost and Maintenance Expenses

The global modular bench-top fermenter system market faces challenges due to high initial acquisition costs and ongoing maintenance expenses. These costs, particularly for small research labs or emerging biotechnology companies, can slow down adoption of these systems, especially in regions with budget constraints. Maintenance and operational expenses are also significant, requiring specialized technical knowledge for setup, calibration, and ongoing maintenance.

For instance, Modular benchtop fermentor systems, such as the Ambr 250 Modular, Winpact One Fermentation System (FS-06), and BioXplorer 100, can vary in cost depending on their features, capacity, and manufacturer. The Ambr 250 Modular is designed for process optimization and can operate with 2 to 8 integrated single-use bioreactors, with prices ranging from $30,000 to $100,000. The Winpact One Fermentation System (FS-06) is a versatile and compact system with prices ranging from $10,000 to $15,000. The BioXplorer 100 is a parallel bioreactor platform with prices ranging from $20,000 to $50,000.

Segment Analysis

The global modular bench-top fermenter system market is segmented based on type, capacity, application, end user and region.

Type:

Temperature and Stirring control module segment is expected to dominate the modular bench-top fermenter system market share

The temperature and stirring control module segment holds a major portion of the modular bench-top fermenter system market share and is expected to continue to hold a significant portion of the modular bench-top fermenter System market share during the forecast period.

Temperature and stirring control modules are crucial in the global modular bench-top fermenter system market, ensuring optimal conditions for microbial growth and product production. They maintain precise control over temperature and agitation, maximizing yield, efficiency, and consistency. The temperature control module maintains the ideal temperature range, promoting enzyme activity and metabolic processes. Proper stirring regulates the agitation speed, ensuring uniform mixing of nutrients, gases, and microorganisms within the fermenter.

These control modules are essential in research and development settings, providing accurate, reproducible results. They also offer flexibility in scaling from laboratory research to pilot and industrial-scale fermentation processes. As demand for more efficient and reliable fermentation processes grows across industries like biotechnology, pharmaceuticals, and biofuels, the role of temperature and stirring control modules in modular bench-top fermenters is expected to become increasingly important, driving their widespread adoption and advancement in the market.

Application:

Microbial fermentation segment is the fastest-growing segment in the modular bench-top fermenter system market share

The microbial fermentation segment is the fastest-growing segment in the modular bench-top fermenter system market share and is expected to hold the market share over the forecast period.

Microbial fermentation is a key application in the global modular bench-top fermenter system market, as it is central to various industries like pharmaceuticals, food production, and biofuels. Modular bench-top fermenters are ideal for microbial fermentation due to their flexibility, ease of scale-up, and precise control over parameters like temperature, pH, oxygen levels, and agitation speed. These systems enable researchers and manufacturers to optimize microbial growth conditions and maximize product yields for antibiotics, enzymes, bio-based chemicals, and renewable energy sources. Modular bench-top fermenters can be customized for small-scale research and pilot studies, as well as large-scale industrial applications. As industries explore sustainable and cost-effective bioprocessing techniques, the demand for modular bench-top fermenters in microbial fermentation is expected to grow, contributing significantly to the global market expansion.

For instance, Sartorius provides scalable benchtop solutions for bioprocess development, including stirred-tank bioreactors and fermenters for batch, fed-batch, and perfusion processes. These bioreactors are suitable for cell cultivation and microbial fermentation, with autoclavable culture vessels available in 1L to 10L and single-use vessels in 250mL and 2L.

Geographical Analysis

North America is expected to hold a significant position in the modular bench-top fermenter system market share

North America holds a substantial position in the modular bench-top fermenter system market and is expected to hold most of the market share due to the presence of advanced research institutions, biotechnology firms, and pharmaceutical companies. These regions are widely used in research, drug development, and biologics production. The region's focus on microbial fermentation processes for vaccine production, biofuels, and pharmaceuticals has further increased demand for customizable, efficient fermenters. Government support, particularly in the U.S., through funding for biotechnology research and well-established infrastructure, further drives market growth.

Europe is growing at the fastest pace in the modular bench-top fermenter system market

Europe holds the fastest pace in the modular bench-top fermenter system market and is expected to hold most of the market share as Europe is experiencing a surge in biotechnological companies and research institutions, focusing on cell culture, microbiology, and bioprocessing. The EU's regulatory framework supports innovation in biotechnology, encouraging modular fermenter systems for various applications. The growing demand for personalized medicine and biologics production in Europe has bolstered the use of these systems, as modular bench-top fermenters offer flexibility for scaling production.

Competitive Landscape

The major global players in the modular bench-top fermenter system market include Electrolab Biotech, Eppendorf AG, Thermo Fisher Scientific Inc, GE Healthcare Life Sciences, Sartorius AG, Merck KGaA, Bioengineering AG, Applikon Biotechnology, Finesse Solutions (A Danaher Company), Labfors (Infors HT) among others.

Emerging Players

The emerging players in the modular bench-top fermenter system market include SUEZ Water Technologies & Solutions, Corning Incorporated, ProTherm, Shenzhen Miuwa Biotechnology Co., Ltd., BioTech, Inc among others.

Key Development

  • In September 2024, VFL Sciences Private Limited has launched the GreatFlo range of Benchtop fermenters/bioreactors, offering versatile models with capacities up to 10 litres. The GreatFlo Expert and Proficient models are built with the latest technologies and are available in autoclavable and in-situ sterilizable versions. The Expert model features a stainless-steel body with a 10.2-inch colour touch screen, and comes with accessories like DO cascades and SCADA software.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global modular bench-top fermenter system market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Component & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Capacity
  • 3.3. Snippet by Application
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing Demand for Biotechnology Research and Development
    • 4.1.2. Restraints
      • 4.1.2.1. High Initial Cost and Maintenance Expenses
    • 4.1.3. Opportunity
      • 4.1.3.1. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. By Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 6.1.2. Market Attractiveness Index, By Type
  • 6.2. Temperature and Stirring Control Module *
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Oxygen Controller

7. By Capacity

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Capacity
    • 7.1.2. Market Attractiveness Index, By Capacity
  • 7.2. Small (up to 5 L) *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Medium (5 L - 50 L)
  • 7.4. Large (Above 50 L)

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Microbial Fermentation*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Cell Culture
  • 8.4. Biochemical Production
  • 8.5. Vaccine Production
  • 8.6. Food & Beverage Processing

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Pharmaceutical and Biotechnology Industry *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Academic and Research Institutions
  • 9.4. Food and Beverage Industry
  • 9.5. Chemical Industry
  • 9.6. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Capacity
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Capacity
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Spain
      • 10.3.7.5. Italy
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Capacity
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Capacity
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Capacity
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Electrolab Biotech*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Eppendorf AG
  • 12.3. Thermo Fisher Scientific Inc
  • 12.4. GE Healthcare Life Sciences
  • 12.5. Sartorius AG
  • 12.6. Merck KGaA
  • 12.7. Bioengineering AG
  • 12.8. Applikon Biotechnology
  • 12.9. Finesse Solutions (A Danaher Company)
  • 12.10. Labfors (Infors HT)

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us